PA8.F Paion AG XETRA 02 Apr 2026 after hours earnings: key numbers set outlook

Paion AG (PA8.F) reported an earnings update after hours on 02 Apr 2026 and the stock trades at EUR 0.0366 on XETRA. The PA8.F stock print shows volume 50 and a market cap of EUR 259,667, with the 50-day average price at EUR 0.02. Today’s after-hours interest follows the company’s earnings announcement and positions PA8.F stock as a high-volatility small cap in the Healthcare sector. We examine the report, key ratios, technicals, and Meyka AI forecasts to outline short-term triggers and realistic price targets for investors.

Earnings snapshot: PA8.F stock after-hours data

Paion AG filed earnings information with an announcement time of 02 Apr 2026; the market shows no intraday change at close with price at EUR 0.0366. Trading volume was light at 50 shares versus an average of 2,162, a sign this stock remains thinly traded on XETRA. Year range is wide: Year High EUR 0.18 and Year Low EUR 0.0002, highlighting large past volatility and low liquidity.

Financials and valuation: PA8.F stock metrics

Paion’s reported metrics show a tiny market cap of EUR 259,667 and shares outstanding 7,133,700. Key ratios include price-to-sales 0.01 and a reported trailing PE of -0.45, reflecting a negative net income per share. Revenue per share is 4.66, while net income per share is -0.08, indicating operating pressure despite high gross margins. There is no dividend yield reported.

Technical and trading: PA8.F stock technicals

Technical indicators show weak momentum: RSI 42.33, MACD roughly flat, and ADX 18.81 indicating no clear trend. Short-term averages place the stock above its 50-day average EUR 0.02 and 200-day average EUR 0.01, suggesting recent strength. Volume profile and OBV remain low, so price moves can be sharp on small orders in this thin market.

Meyka grade and forecast: PA8.F stock analysis

Meyka AI rates PA8.F with a score out of 100: 62.73 (Grade B, Suggestion: HOLD). This grade factors S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst consensus. Meyka AI’s forecast model projects a monthly target EUR 0.11, a quarterly EUR 0.01, and a yearly EUR 0.00418. Compared with the current price EUR 0.0366, the monthly projection implies +200.55% upside while the yearly projection implies -88.56% downside. Forecasts are model-based projections and not guarantees.

Price targets and analyst-style outlook for PA8.F stock

We set three practical targets: conservative EUR 0.02 (implied -45.36%), base EUR 0.05 (implied +36.61%), and optimistic EUR 0.11 (implied +200.55%). These reflect sector peers in Healthcare that trade at higher liquidity and valuation multiples; Paion’s low EV-to-sales 0.01 and thin float justify a wide target band. Catalysts that could validate higher targets include successful regulatory updates or stronger commercial traction for short-acting sedatives.

Risks, catalysts and trading strategy for PA8.F stock

Key risks include extreme liquidity constraints, path-dependent clinical outcomes, and limited public financial disclosure. Catalysts are binary: trial results or licensing deals could lift the stock quickly, while missed milestones could erase value. Traders should size positions for micro-cap volatility, use limit orders on XETRA, and consider stop levels given the low average volume of 2,162 shares.

Final Thoughts

Paion AG (PA8.F) finished the regular session unchanged at EUR 0.0366 on XETRA after an earnings update on 02 Apr 2026. The PA8.F stock sits in a risky but event-driven category: low market cap EUR 259,667, thin liquidity, and mixed financial signals. Meyka AI rates PA8.F 62.73/100 (B, HOLD) and provides a range of model forecasts from EUR 0.00418 (yearly) to EUR 0.11 (monthly). Our preferred scenario treats EUR 0.05 as a practical base-case price target, implying +36.61% upside from the current price, with a conservative stop below EUR 0.02. Investors should weigh company-specific catalysts against severe liquidity and binary clinical risks. For active traders, watch post-earnings headlines and order book depth; for longer-term investors, require clearer financials or licensing visibility before increasing exposure. Meyka AI’s data-driven grade and forecasts are part of our analytical toolkit and are not investment advice. For the latest market moves and to track PA8.F stock in real time see Paion AG on Meyka and the latest market notes on Investing.com.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.